Abstract
The human immunodeficiency virus (HIV) pandemic has continued despite the advent of new antiviral therapies; this is responsible for an increase in the number of patients with this entity and its survival. The majority of ocular manifestations of HIV infection involve the posterior segment of the eye. Prior to the introduction of highly active antiretroviral therapy (HAART), retinal microvasculopathy and cytomegalovirus (CMV) retinitis accounted for more than 80% of the ocular complications in HIV-positive patients. To date, HIV disease and CMV retinitis have become chronic diseases. Many challenges remain to be addressed. HAART has indeed decreased the incidence of some ophthalmic problems, such as CMV retinitis, and it has brought with it new challenges, such as immune recovery uveitis (IRU). Ocular disorders associated with HIV disease remain important problems in the world, despite HAART, and increasingly are more significant and frequent. The approach to diagnosis and management of different pathological presentations at the posterior pole is very important.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
